Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > ALL ABOARD. THE TRAIN IS LEAVING

<< Previous

Bullboard Posts

Next >>

Comment by Bigginvestoron May 14, 2021 10:49am

176 Views

Post# 33203159

RE:RE:RE:RE:ALL ABOARD. THE TRAIN IS LEAVING

PTBailey wrote:
Scotty wrote: I can't speak for him but I imagine it's the same motivation as mine. This is a shell scam obviously, I want to warn future investors of this fact.

But for what reason? Are you on other boards doing the same?

If what you say is true I for one would get out asap. Can you provied factual evidence of that?

Scotty need to get a life

<< Previous

Bullboard Posts

Next >>

Bombardier delivers Global 6500 aircraft to U.S. army